EPS Bio Technology Corp. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was TWD 477.598 million compared to TWD 459.346 million a year ago. Operating income was TWD 44.159 million compared to TWD 27.731 million a year ago. Net income was TWD 31.701 million compared to TWD 18.438 million a year ago. Basic earnings per share was TWD 1.33 compared to TWD 0.77 a year ago.